238 related articles for article (PubMed ID: 16445293)
21. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
[TBL] [Abstract][Full Text] [Related]
22. Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor.
Plazas PV; Katz E; Gomez-Casati ME; Bouzat C; Elgoyhen AB
J Neurosci; 2005 Nov; 25(47):10905-12. PubMed ID: 16306403
[TBL] [Abstract][Full Text] [Related]
23. Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.
Azam L; Dowell C; Watkins M; Stitzel JA; Olivera BM; McIntosh JM
J Biol Chem; 2005 Jan; 280(1):80-7. PubMed ID: 15520009
[TBL] [Abstract][Full Text] [Related]
24. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
25. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
[TBL] [Abstract][Full Text] [Related]
26. Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets.
Chhabra S; Belgi A; Bartels P; van Lierop BJ; Robinson SD; Kompella SN; Hung A; Callaghan BP; Adams DJ; Robinson AJ; Norton RS
J Med Chem; 2014 Dec; 57(23):9933-44. PubMed ID: 25393758
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
Jiang S; Tae HS; Xu S; Shao X; Adams DJ; Wang C
Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28598389
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.
Holt JC; Kewin K; Jordan PM; Cameron P; Klapczynski M; McIntosh JM; Crooks PA; Dwoskin LP; Lysakowski A
J Neurosci; 2015 Feb; 35(8):3625-43. PubMed ID: 25716861
[TBL] [Abstract][Full Text] [Related]
29. α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy.
Dyachenko IA; Palikova YA; Palikov VA; Korolkova YV; Kazakov VA; Egorova NS; Garifulina AI; Utkin YN; Tsetlin VI; Kryukova EV
Biochimie; 2022 Mar; 194():127-136. PubMed ID: 34979156
[TBL] [Abstract][Full Text] [Related]
30. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
31. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
[TBL] [Abstract][Full Text] [Related]
32. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
33. Cy3-RgIA-5727 Labels and Inhibits α9-Containing nAChRs of Cochlear Hair Cells.
Fisher F; Zhang Y; Vincent PFY; Gajewiak J; Gordon TJ; Glowatzki E; Fuchs PA; McIntosh JM
Front Cell Neurosci; 2021; 15():697560. PubMed ID: 34385908
[TBL] [Abstract][Full Text] [Related]
34. Alpha4/3 conotoxins: phylogenetic distribution, functional properties, and structure-function insights.
Ellison M; Olivera BM
Chem Rec; 2007; 7(6):341-53. PubMed ID: 18050267
[TBL] [Abstract][Full Text] [Related]
35. alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
Johnson DS; Martinez J; Elgoyhen AB; Heinemann SF; McIntosh JM
Mol Pharmacol; 1995 Aug; 48(2):194-9. PubMed ID: 7651351
[TBL] [Abstract][Full Text] [Related]
36. Dicarba α-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors.
van Lierop BJ; Robinson SD; Kompella SN; Belgi A; McArthur JR; Hung A; MacRaild CA; Adams DJ; Norton RS; Robinson AJ
ACS Chem Biol; 2013 Aug; 8(8):1815-21. PubMed ID: 23768016
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling of the alpha9alpha10 nicotinic acetylcholine receptor subtype.
Pérez EG; Cassels BK; Zapata-Torres G
Bioorg Med Chem Lett; 2009 Jan; 19(1):251-4. PubMed ID: 19013796
[TBL] [Abstract][Full Text] [Related]
38. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
39. The three-dimensional structure of the analgesic alpha-conotoxin, RgIA.
Clark RJ; Daly NL; Halai R; Nevin ST; Adams DJ; Craik DJ
FEBS Lett; 2008 Mar; 582(5):597-602. PubMed ID: 18242183
[TBL] [Abstract][Full Text] [Related]
40. Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting α9α10 Nicotinic Acetylcholine Receptor.
Huang Q; Chu X; Zhang H; Yu S; Zhang L; Zhang X; Yu R; Guo C; Dai Q
ACS Chem Biol; 2022 Sep; 17(9):2483-2494. PubMed ID: 36048451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
